Literature DB >> 18752052

Poly(adenosine diphosphate-ribose) polymerase-1 expression in cutaneous malignant melanomas as a new molecular marker of aggressive tumor.

Béla Csete1, Zsuzsanna Lengyel, Zsolt Kádár, Zita Battyáni.   

Abstract

Poly(adenosine diphosphate-ribose) polymerases (PARPs) are a family of enzymes, which catalyses poly (ADP-ribosyl)ation of DNA-binding proteins and directly involved in genomic stability, DNA repair, and apoptosis. In this study, we evaluated the immunomorphology of PARP-1 in melanoma and its prognostic importance. We studied PARP-1 expression by immunohistochemistry in a selected series of 54 primary cutaneous malignant melanoma (CMM). The findings of the present study suggest that the neoplastic progression toward the invasive (both horizontal and vertical) growth phase of CMM cells is characterized by the loss of cleavage of PARP-1, probably signaling an imbalance of the apoptotic process in these cells and leading to further gain to aggression. Over-expression of full-length PARP-1 was correlated with recurrence and/or progression of the disease and so act as a promising new biological marker of CMM. Our study represents the evidence of a direct correlation between the PARP-1-mediated apoptotic process and the biologic behavior of CMM.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18752052     DOI: 10.1007/s12253-008-9086-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  17 in total

1.  Poly(adenosine diphosphate-ribose) polymerase 1 expression in malignant melanomas from photoexposed areas of the head and neck region.

Authors:  Stefania Staibano; Stefano Pepe; Lorenzo Lo Muzio; Pasquale Somma; Massimo Mascolo; Giuseppe Argenziano; Massimiliano Scalvenzi; Gaetano Salvatore; Gabriella Fabbrocini; Guido Molea; Angelo Raffaele Bianco; Chiara Carlomagno; Gaetano De Rosa
Journal:  Hum Pathol       Date:  2005-07       Impact factor: 3.466

2.  Mechanism of early biphasic activation of poly(ADP-ribose) polymerase-1 in response to ultraviolet B radiation.

Authors:  Momchil D Vodenicharov; Medini M Ghodgaonkar; Sabina S Halappanavar; Rashmi G Shah; Girish M Shah
Journal:  J Cell Sci       Date:  2005-01-18       Impact factor: 5.285

Review 3.  Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease.

Authors:  M Masutani; H Nakagama; T Sugimura
Journal:  Cell Mol Life Sci       Date:  2005-04       Impact factor: 9.261

4.  Effects of the isoflavone 4',5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage.

Authors:  Eileen Q Shyong; Yuhun Lu; Alison Lazinsky; Rao N Saladi; Robert G Phelps; Lisa M Austin; Mark Lebwohl; Huachen Wei
Journal:  Carcinogenesis       Date:  2002-02       Impact factor: 4.944

5.  Expression of apoptosis regulators in cutaneous malignant melanoma.

Authors:  L Tang; V A Tron; J C Reed; K J Mah; M Krajewska; G Li; X Zhou; V C Ho; M J Trotter
Journal:  Clin Cancer Res       Date:  1998-08       Impact factor: 12.531

Review 6.  The PARP superfamily.

Authors:  Jean-Christophe Amé; Catherine Spenlehauer; Gilbert de Murcia
Journal:  Bioessays       Date:  2004-08       Impact factor: 4.345

7.  bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death.

Authors:  L H Boise; M González-García; C E Postema; L Ding; T Lindsten; L A Turka; X Mao; G Nuñez; C B Thompson
Journal:  Cell       Date:  1993-08-27       Impact factor: 41.582

8.  Poly(ADP-ribosyl)ation is required for p53-dependent signal transduction induced by radiation.

Authors:  X Wang; K Ohnishi; A Takahashi; T Ohnishi
Journal:  Oncogene       Date:  1998-12-03       Impact factor: 9.867

9.  Bcl-2 expression in human melanocytes and melanocytic tumors.

Authors:  J J van den Oord; N Vandeghinste; M De Ley; C De Wolf-Peeters
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  [Malignant melanoma in life insurance--thickness or anatomic layer?].

Authors:  W A Müller; M Erlanger
Journal:  Versicherungsmedizin       Date:  1994-12-01
View more
  9 in total

1.  Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.

Authors:  Ho-Cheol Kim; Joon Seon Song; Jae Cheol Lee; Dae Ho Lee; Sang-We Kim; Jung-Shin Lee; Woo Sung Kim; Jin Kyung Rho; Sun Ye Kim; Chang-Min Choi
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

2.  PARP-1 and PARP-2: New players in tumour development.

Authors:  José Yelamos; Jordi Farres; Laura Llacuna; Coral Ampurdanes; Juan Martin-Caballero
Journal:  Am J Cancer Res       Date:  2011-01-08       Impact factor: 6.166

3.  Expression of BAG-1 and PARP-1 in precursor lesions and invasive cervical cancer associated with human papillomavirus (HPV).

Authors:  Marcela Kazue Hassumi-Fukasawa; Fabiana Alves Miranda-Camargo; Bruna Riedo Zanetti; Denise Faria Galano; Alfredo Ribeiro-Silva; Edson Garcia Soares
Journal:  Pathol Oncol Res       Date:  2012-03-28       Impact factor: 3.201

4.  Pediatric high-grade glioma: identification of poly(ADP-ribose) polymerase as a potential therapeutic target.

Authors:  Stuart J Smith; Angela Long; Jennifer H Barrow; Donald C Macarthur; Beth Coyle; Richard G Grundy
Journal:  Neuro Oncol       Date:  2011-08-17       Impact factor: 12.300

5.  Downregulation of Human DAB2IP Gene Expression in Renal Cell Carcinoma Results in Resistance to Ionizing Radiation.

Authors:  Eun-Jin Yun; Chun-Jung Lin; Andrew Dang; Elizabeth Hernandez; Jiaming Guo; Wei-Min Chen; Joyce Allison; Nathan Kim; Payal Kapur; James Brugarolas; Kaijie Wu; Dalin He; Chih-Ho Lai; Ho Lin; Debabrata Saha; Seung Tae Baek; Benjamin P C Chen; Jer-Tsong Hsieh
Journal:  Clin Cancer Res       Date:  2019-04-18       Impact factor: 12.531

6.  Poly (ADP-ribose) polymerase 1 protein expression in normal and neoplastic prostatic tissue.

Authors:  M Salemi; A Galia; F Fraggetta; C La Corte; P Pepe; S La Vignera; G Improta; P Bosco; A E Calogero
Journal:  Eur J Histochem       Date:  2013-04-15       Impact factor: 3.188

7.  Inhibition of poly(ADP-ribose) polymerase 1 protects against acute myeloid leukemia by suppressing the myeloproliferative leukemia virus oncogene.

Authors:  Lingbo Wang; Weili Cai; Wei Zhang; Xueying Chen; Wenqian Dong; Dongqi Tang; Yun Zhang; Chunyan Ji; Mingxiang Zhang
Journal:  Oncotarget       Date:  2015-09-29

8.  PARP1 Inhibitors: antitumor drug design.

Authors:  N V Malyuchenko; E Yu Kotova; O I Kulaeva; M P Kirpichnikov; V M Studitskiy
Journal:  Acta Naturae       Date:  2015 Jul-Sep       Impact factor: 1.845

9.  Crystal structure-based discovery of a novel synthesized PARP1 inhibitor (OL-1) with apoptosis-inducing mechanisms in triple-negative breast cancer.

Authors:  Leilei Fu; Shuya Wang; Xuan Wang; Peiqi Wang; Yaxin Zheng; Dahong Yao; Mingrui Guo; Lan Zhang; Liang Ouyang
Journal:  Sci Rep       Date:  2016-12-05       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.